Target intelligence / Profile preview

Transmembrane serine protease 11B (TMPRSS11B)

Target
TMPRSS11B
Molecular classification
Enzyme, Serine protease, Transmembrane protein
01

Overview

Transmembrane serine protease 11B (TMPRSS11B) is a cell surface serine protease involved in proteolytic processes in epithelial tissues. TMPRSS11B is highly expressed in the plasma membrane and enhances lactate export by promoting the solubilization of Basigin, the chaperone for the monocarboxylate transporter MCT4, leading to increased glycolytic metabolism in cancer cells. This activity is crucial for tumorigenesis in lung squamous cell carcinoma, and high TMPRSS11B expression correlates with poor prognosis in lung cancer patients. TMPRSS11B may be a novel therapeutic target in cancer, especially because it is accessible on the cell membrane and functionally linked to metabolic pathways[1][3][8][9].

Other names
HATL5Airway trypsin-like protease 5Transmembrane protease serine 11BTMPRSS11B
02

Mechanism of action

Inhibition of serine protease activity (by aforementioned inhibitors)[9]. Potential interruption of metabolic reprogramming in cancer cells by blocking the solubilization of Basigin and subsequent lactate export[1].

03

Biological functions

ProteolysisRegulation of lactate exportRegulation of glycolytic metabolismModulation of cancer cell metabolism
04

Disease associations

CancerLung cancer (particularly lung squamous cell carcinoma)Tumorigenesis
05

Safety considerations

Not well established; possible safety considerations may arise from interference with normal epithelial protease functions and metabolic processes, but data are lacking.
06

Interacting drugs

None currently identified for clinical use; experimental inhibition with protease inhibitors (such as aprotinin, leupeptin, benzamidine, SERPINA1, SPINT1, SPINT2) has been reported in vitro[9].
07

Biomarkers

High TMPRSS11B expression is associated with poor survival in non-small cell lung cancer (NSCLC), particularly lung squamous cell carcinoma[1].TMPRSS11B upregulation may serve as a prognostic biomarker in lung cancer[1].

Beyond the preview

Go deeper on Transmembrane serine protease 11B (TMPRSS11B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane serine protease 11B (TMPRSS11B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call